LINDA Investor Relations
Invest in progress and change the future of breast cancer treatment and prevention.
LINDA is committed to championing the health of women worldwide with innovative breast cancer care solutions. Our patent-pending technology has been shown to be as safe and effective as mammography for early detection. Already, more than 40,000 women have been tested with LINDA, 40% of whom had never received a screening before.
With $1.5M in funding raised to date and an international team of experts with over 20 years of experience, LINDA stands at the forefront of healthtech, ready to make breast cancer prevention a reality for all women.
Change for good.
Milestones and accomplishments.
LINDA has a proven history of achievement.
2019
LINDA is founded in São Paulo, Brazil after two years of development.
2020
LINDA receives Anvisa approval and begins clinical trials in Brazil.
2023
LINDA is named best healthtech startup at the G20 digital innovation summit.
2024
LINDA begins clinical trials in Canada with the Princess Margaret Cancer Centre.
2025 & Beyond
LINDA aims to enter the market in America by 2025 and Europe by 2024.
Supported by
Reach out today to find out more.
Have a question? We're here to help!